Testosterone Does Not Treat OCD and May Worsen Psychiatric Symptoms
Testosterone therapy is not a treatment for obsessive-compulsive disorder, and current evidence suggests testosterone may actually worsen psychiatric symptoms including depression and suicidality. The established first-line treatments for OCD remain cognitive-behavioral therapy with exposure and response prevention (ERP) and selective serotonin reuptake inhibitors (SSRIs) 1.
Why Testosterone Is Not Indicated for OCD
Lack of Evidence for Therapeutic Benefit
The comprehensive OCD treatment guidelines from 2019 make no mention of testosterone as a treatment option 1. The established treatment algorithm prioritizes:
- First-line: CBT with ERP or SSRIs
- Second-line: Combination therapy, switching SSRIs, or augmentation with antipsychotics
- Refractory cases: Clomipramine, glutamatergic agents, or neurosurgery
Testosterone does not appear anywhere in this evidence-based hierarchy.
Anti-Androgenic Treatment Shows Promise Instead
Paradoxically, reducing testosterone may help OCD symptoms. A small open-label trial found that 5 out of 6 male patients with therapy-resistant OCD experienced considerable improvement when treated with triptorelin, a long-acting GnRH analogue that suppresses testosterone production 2. This suggests that lowering androgens, not increasing them, may be beneficial in OCD.
Neurosteroid Dysregulation in OCD
Research shows that male OCD patients actually have lower testosterone levels compared to controls, along with elevated cortisol 3. This pattern suggests hypothalamic-pituitary-gonadal (HPG) axis dysfunction. Female OCD patients show elevated DHEA and cortisol, indicating HPA axis involvement 3, 4. These findings suggest OCD involves complex neuroendocrine dysregulation, not simple testosterone deficiency.
Significant Safety Concerns with Testosterone
Psychiatric Risks
Testosterone therapy is independently associated with major depressive disorder (OR 1.99) and suicide attempts/intentional self-harm (OR 1.52) in a large retrospective cohort study of over 70 million electronic health records 5. This association remained significant even in testosterone-deficient men receiving replacement therapy. Given that OCD patients already experience significant psychiatric comorbidity, adding testosterone could substantially increase risk.
FDA-Labeled Precautions
The FDA label for testosterone warns about mood effects and states it should not be used in nursing mothers and has not been established as safe in pediatric patients under 12 6. The label emphasizes testosterone's role in normal male development but provides no indication for psychiatric conditions.
Evidence-Based OCD Treatment Algorithm
Step 1: Initial Treatment
- CBT with ERP (10-20 sessions, number needed to treat = 3) OR
- SSRI monotherapy at high doses (8-12 weeks trial, number needed to treat = 5)
- Choice depends on: patient preference, CBT availability, comorbidities requiring medication 1
Step 2: Inadequate Response
- Combine SSRI + CBT (most effective augmentation strategy) 1
- Switch to different SSRI or try clomipramine
- Consider intensive CBT protocols 1
Step 3: Treatment-Resistant OCD
- SSRI augmentation with antipsychotics (risperidone or aripiprazole) 1
- Clomipramine plus SSRI (monitor for drug interactions and serotonin syndrome) 1
- Glutamatergic agents 1
Step 4: Severe Refractory Cases
- Intensive residential treatment
- Neurosurgery including deep brain stimulation 1
Clinical Pitfalls to Avoid
- Do not prescribe testosterone for OCD symptoms - no evidence supports this, and psychiatric risks are substantial
- Do not confuse neurosteroid dysregulation with testosterone deficiency - the pattern in OCD suggests complex axis dysfunction, not simple hormone replacement
- Do not delay evidence-based treatment - SSRIs and CBT have robust efficacy data; pursuing unproven hormonal interventions wastes valuable treatment time
- Screen for depression and suicidality if testosterone is being used for legitimate hypogonadism in a patient who also has OCD 5
The evidence is clear: testosterone has no role in OCD treatment and may cause harm through psychiatric adverse effects. Stick to the proven treatment algorithm of CBT with ERP and SSRIs 1, 7, 8, 9.